Essex Investment Management CO LLC Ultragenyx Pharmaceutical Inc. Transaction History

Essex Investment Management CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$34.92 - $46.66 $453 - $606	-13 Reduced 0.87%	1,481 $52,000
Q1 2023 May 04, 2023	SELL	$36.99 - $48.71 $665 - $876	-18 Reduced 1.19%	1,494 $59,000
Q2 2022 Aug 12, 2022	SELL	$45.8 - $85.4 $53,586 - $99,918	-1,170 Reduced 43.62%	1,512 $90,000
Q1 2022 May 09, 2022	BUY	$62.2 - $84.4 $21,645 - $29,371	348 Added 14.91%	2,682 $195,000
Q4 2021 Feb 10, 2022	SELL	$73.71 - $87.86 $26,904 - $32,068	-365 Reduced 13.52%	2,334 $196,000
Q2 2021 Aug 12, 2021	SELL	$92.19 - $115.71 $8,204 - $10,298	-89 Reduced 3.19%	2,699 $257,000
Q1 2021 May 12, 2021	BUY	$106.9 - $167.73 $42,225 - $66,253	395 Added 16.51%	2,788 $317,000
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $174,641 - $215,370	2,393 New	2,393 $197,000

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.